Angiogenesis pp 113-120 | Cite as

Inflammatory Angiogenic Factors in a Model of Chronic Inflammation

  • James D. Winkler
  • Michael P. Seed
  • Jeffrey R. Jackson
Part of the NATO ASI Series book series (NSSA, volume 298)


In many diseases, there is an apparent co-dependence of inflammation and angiogenesis. There’s a very strong inflammatory component in rheumatoid arthritis, psoriasis, inflammatory bowel disease, during tumor growth and in some angiogenic ocular disorders. Many of the mediators that we think about in inflammation can promote angiogenesis, such as some interleukins, TNFa, prostaglandins, arachidonic acid metabolites and platelet-activating factor. Some of these appear to act indirectly by changing the balance between angiogenesis stimulation and inhibition, promoting the production of some of the more directly acting angiogenesis inducers, such as VEGF.

We have been using an animal model to study angiogenesis in an inflammatory setting, an air pouch granuloma model, in which there is an inflammatory response and the formation of granulomatous tissue. We have assessed the characteristics of this granuloma over time, it’s weight, histological structure, vascular volume, cellularity and mediators produced. Many of these characteristics change during time after the start of granuloma growth.

We have characterized a number of different classes of compounds in this model. Protamine and the angiostatic steroid medroxyprogesterone each blocked about fifty percent of the angiogenesis produced by adjuvant and croton oil injection. SB 203347, an inhibitor of class II, fourteen kDa PLA2, an enzyme thought to be responsible for the production of leukotrienes and platelet-activating factor, produced a striking reduction in the angiogenic response in mice. Inhibitors of p38 MAP kinase were also found to cause a dose-related inhibition of the angiogenic response. These compounds block the production of cytokines, such as TNFa and IL lb.

Thus, in this model of inflammatory angiogenesis, inhibitors of inflammatory mediator production block angiogenesis, possibly by tipping the balance against the production of pro-angiogenic mediators.


Vascular Endothelial Growth Factor Angiogenic Response Vascular Index Psoriatic Keratinocytes Inflammatory Angiogenesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Appleton, I., Tomlinson, A., Colville-Nash, P.R. and Willoughby, D.A., 1993, Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue, Lab. Invest. 69:405–414.PubMedGoogle Scholar
  2. Appleton, I., Brown, N.J., Willis, D., Colville-Nash, P.R., Alam, C., Brown, J.R. and Willoughby, D.A., 1996, The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis, J. Pathol. 180:90–94.PubMedCrossRefGoogle Scholar
  3. Ben-Av, P., Crofford, L.J., Wilder, R.L. and Ha, T., 1995, Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1 : a potential mechanism for inflammatory angigenesis, FEBS Lett 372:83–87.PubMedCrossRefGoogle Scholar
  4. BenEzra, D., Hemo, I. and Maftzir, G., 1990, In vivo angiogenic activity of interleukins, Arch Opthamol 108:573–576.CrossRefGoogle Scholar
  5. Camussi, G., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A. and Bussolino, F., 1995, Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism, J. Immunol. 154:6492–6501.PubMedGoogle Scholar
  6. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G. and Levi, B.Z., 1996, Interleukin-6 induces the expression of vascular endothelial growth-factor, J Biol Chem 271:736–741.PubMedCrossRefGoogle Scholar
  7. Colville-Nash, P.R., Seed, M.P. and Willoughby, D.A., 1992, Anti-rheumatic drugs and the development of vasculature in murine chronic granulomatous air pouches, Br J Pharmacol 107:421P.Google Scholar
  8. Colville-Nash, P.R. and Seed, M.P., 1993, The current state of angiostatic therapy, with special reference to rheumatoid arthritis, Curr Opin Invest Drugs 2:763–813.Google Scholar
  9. Colville-Nash, P.R, Alam, C.A.S., Appleton, I., Browne, J.R., Seed, M.P. and Willoughby, D.A., 1995, The pharmacological modulation of angiogenesis in chronic granulomatous inflammation, J Pharmacol Exp Ther 274:1463–1472.PubMedGoogle Scholar
  10. Fajardo, L.F., Kwan, H.H., Kowalski, J., Prionas, S.D. and Allison, A.C., 1992, Dual role of tumor necrosis factor-a in angiogenesis, Am J Pathol 140:539–544.PubMedGoogle Scholar
  11. Folkman, J., 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med. 1:27–31.PubMedCrossRefGoogle Scholar
  12. Folkman, J. and Brem, H., Angiogenesis and inflammation. In: J.I. Gallin, I.M. Goldstein and R. Snyderman (Eds), Inflammation: Basic Principles and Clinical Correlates, Second Edition, Vol. 2, Raven Press, Ltd, New York, 1992, pp. 821–839.Google Scholar
  13. Jackson, J.R., Bolognese, B., Hillegass, L., Adams, J., Griswold, D.E. and Winkler, J.D., 1997a, The role of CSBP, p38, a stress response MAP kinase, in angiogenesis and chronic inflammatory disease models, submitted.Google Scholar
  14. Jackson, J.R., Bolognese, B., Hubbard, W.C., Marshall, L.A. and Winkler, J.D., 1997b, Platelet-activating factor derived from 14 kDa phospholipase A2 contributes to inflammatory angiogenesis, Submitted Google Scholar
  15. Jackson, J.R., Bolognese, B., Kircher, C.H., Marshall, L.A. and Winkler, J.D., 1997c, Modulation of angiogenesis in a model of chronic inflammation, Inflammation Research in press. Google Scholar
  16. Jackson, J.R., Minton, J.A.L., Ho, M.L., Wei, N. and Winkler, J.D., 1997d, Expression of VEGF in synovial fibroblasts is induced by hypoxia and interleukin-lb, J. Rheum, in press.Google Scholar
  17. Jackson, J.R., Seed, M.P., Kircher, C.H., Willoughby, D.A. and Winkler, J.D., 1997e, The co-dependence of angiogenesis and chronic inflammation, FASEB J. 11:457–465.PubMedGoogle Scholar
  18. Kimura, M., Suzuki, J. and Amemiya, K., 1985, Mouse granuloma pouch induced by freund’s complete adjuvant with croton oil, J Pharmacobio-Dyn 8:393–400.PubMedCrossRefGoogle Scholar
  19. Kimura, M., Amemiya, K., Yamada, T. and Suzuki, J., 1986, Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice, J Pharmacobio-Dyn 9:442–446.PubMedCrossRefGoogle Scholar
  20. Li, J., Perrella, M.A., Tsai, J.-C., Yet, S.-F., Hsieh, C.-M., Yoshizumi, M., Patterson, C., Endege, W.O., Zhou, F. and Lee, M.-E., 1995, Induction fo vascular endothelial growth factor gene expression by interleukin-lb in rat aortic smooth muscle cells, J Biol Chem 270:308–312.PubMedCrossRefGoogle Scholar
  21. Nagashima, M., Yoshino, S., Ishiwata, T. and Asano, G., 1995, Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis, J Rheum 22:1624–1630.PubMedGoogle Scholar
  22. Nickoloff, B.J., Mitra, R.S., Varani, J., Dixit, V.M. and Polverini, P.J., 1994, Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis, Am J Pathol 144:820–828.PubMedGoogle Scholar
  23. Seed, M.P., Colville-Nash, P.R., Jackson, J.R. and Winkler, J.D., Angiogenesis in inflammation. In: T.-P. Fan and R. Auerbach (Eds.), The new angiotherapy, Humana Press, 1997, pp. In press.Google Scholar
  24. Shima, D.T., Adamis, A.P., Ferrara, N., Yeo, K.T., Yeo, T.K., Allende, R., Folkman, J. and Damore, P.A., 1995, Hypoxic induction of endothelial-cell growth-factors in retinal cells -identification and characterization of vascular endothelial growth-factor (vegf) as the mitogen, Molecular Medicine 1:182–193.PubMedGoogle Scholar
  25. Shweiki, D., Neeman, M., Itin, A. and Keshet, E., 1995, Induction of vascular endothelial growth-factor expression by hypoxia and by glucose deficiency in multicell spheroids -implications for tumor angiogenesis, Proc Natl Acad Sci USA 92:768–772.PubMedCrossRefGoogle Scholar
  26. Spisni, E., Manica, F. and Tomasi, V., 1992, Involvement of prostanoids in the regulation of angiogenesis by peptide growth factors, Pros. Leuko. Essen. Fatty Acids 47:111–115.CrossRefGoogle Scholar
  27. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C., 1994, Macrophages and angiogenesis, J Leuk Biol 55:410–422.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • James D. Winkler
    • 1
  • Michael P. Seed
    • 2
  • Jeffrey R. Jackson
    • 1
  1. 1.Department of ImmunopharmacologySmithKline Beecham PharmaceuticalsKing of PrussiaUSA
  2. 2.Department of Experimental Pathology, The William Harvey Research InstituteSt. Bartholomew’s Hospital Medical CollegeLondonUK

Personalised recommendations